-
R-Pharm US was established in 2014 and located in Princeton, NJ
-
Fully integrated specialty pharmaceutical company focused on the development and commercialization of medicines to treat cancer and chronic immune diseases
Product Spotlight:
R-PHARM US Acquired IXEMPRA® (ixabepilone) from Bristol-Myers Squibb and has treated more than 20,000 metastatic breast cancer patients in the last six years.
To see full US Prescribing Information for IXEMPRA, including Boxed Warning regarding hepatic impairment, click on www.Ixempra.com.